Thermo Fisher Scientific's PPD Business Gets NIH Contract for Neurological Device Development

Thermo Fisher Scientific’s PPD clinical research business, based in Wilmington, was awarded a five-year contract to provide regulatory affairs support and related services for the NIH’s new Blueprint MedTech program, which supports development of translational neurological devices.

Related Keywords

North Carolina ,United States ,Davidm Johnston ,Randall Johnson ,National Institute On Drug Abuse ,Ncbiotech Southeastern Office ,Department Of Health ,Human Services ,Thermo Fisher ,Thermo Fisher Scientific ,Blueprint Medtech ,Southeastern Office ,North Carolina Biotechnology ,National Institute ,Drug Abuse ,